Location History:
- Union City, CA (US) (2023)
- Fremont, CA (US) (2020 - 2024)
Company Filing History:
Years Active: 2020-2025
Title: Innovations of Krishna Bajjuri in Antibody Conjugates
Introduction
Krishna Bajjuri is a prominent inventor based in Fremont, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of antibody conjugates. With a total of 5 patents to his name, Bajjuri's work focuses on innovative therapeutic solutions.
Latest Patents
His latest patents include "Anti-ROR1 antibody conjugates," "compositions comprising anti-ROR1 antibody conjugates," and "methods of making and using anti-ROR1 antibody conjugates." These patents relate to antibodies and antibody conjugates that specifically bind to receptor tyrosine kinase orphan receptor 1 (ROR1) and its isoforms and homologs. The disclosures also cover pharmaceutical compositions and methods for producing and utilizing these antibodies in therapeutic and diagnostic applications.
Career Highlights
Krishna Bajjuri is currently associated with Sutro Biopharma, Inc., where he continues to advance his research in antibody drug conjugates. His work has the potential to impact various therapeutic areas, particularly in cancer treatment.
Collaborations
Some of his notable coworkers include Alice Yam and Andreas Maderna, who contribute to the collaborative environment at Sutro Biopharma, Inc. Their combined expertise enhances the innovative efforts within the company.
Conclusion
Krishna Bajjuri's contributions to the field of antibody conjugates exemplify the importance of innovation in biotechnology. His patents and ongoing research are paving the way for new therapeutic options in medicine.